Venetoclax with Azacitidine Induced Tumor Lysis Syndrome in an Elderly Patient with Acute Myeloid Leukemia: A Case Report

Combination treatment with hypomethylating agents (HMAs) and venetoclax is being used increasingly in elderly patients with acute myeloid leukemia (AML). Venetoclax with HMAs has been reported to be associated with tumor lysis syndrome (TLS) in AML patients with high leukemic burden. We present a ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mihee, Bang, Hyun-Jin, Song, Ga-Young, Ahn, Seo-Yeon, Jung, Sung-Hoon, Song, Yong-Su, Ahn, Jae-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Electrolyte Metabolism 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715223/
https://www.ncbi.nlm.nih.gov/pubmed/35003285
http://dx.doi.org/10.5049/EBP.2021.19.2.46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715223/
https://www.ncbi.nlm.nih.gov/pubmed/35003285
http://dx.doi.org/10.5049/EBP.2021.19.2.46

Ejemplares similares